JB
Jupiter Biomedical Research, Inc.
StreetZero Signal 60
About Jupiter Biomedical Research, Inc.
Jupiter Biomedical Research, Inc. focuses on developing medical therapies within the biotechnology sector, specifically targeting cancer and viral infections. The company is advancing two primary drug candidates: JBR-102, an oral formulation for the treatment of various cancers, and JBR-201, an antiviral therapeutic. It is headquartered in Palm Beach Gardens, Florida.
LATEST FUNDINGPrivate Placement
$30K
Announced 2026-09-21
TOTAL RAISED$30,000
IN THE NEWS
- 🔗 Jupiter Biomedical Research - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 Jupiter.bio
- 🔗 Former FDA leader launches $70M biotech fund
- 🔗 Myosin Therapeutics lands $2 million cancer research grant from state of Florida - South Florida Business Journal
- 🔗 Oxford Biomedical Research, Inc. Company Overview, Contact Details & Competitors | LeadIQ
EMPLOYEES—
FOUNDED—
HQPalm Beach Gardens, FL, USA
Industry
Biotechnology
Tags
BiotechnologyCancerAntiviral
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed a $30,000 private placement with undisclosed investors.
- Developing JBR-102 oral therapy for multiple cancers.
- Advancing JBR-201 as an antiviral candidate.
- Located in Palm Beach Gardens, Florida.
Ask StreetZero about Jupiter Biomedical Research, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account